Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial In Cystinosi...
Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP), announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ("DR Cystea...
Medical News Today,
Tue Nov 24 04:36:45 PST 2009
• Found on Yahoo! News
Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosi...
NOVATO, California, November 23 /PRNewswire/ -- - Goal of Trial Achieved Demonstrating Potentially Less Frequent Administration Using Lower Daily Dose Raptor Pharmaceutical Corp. ("Raptor" ...
ITNews,
Mon Nov 23 03:44:31 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News
Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosi...
Raptor Pharmaceutical Corp. , today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate in patients with nephropathic cystinosis .
PR Newswire via Yahoo! Finance,
Mon Nov 23 03:30:00 PST 2009
• Found on Yahoo! News
Raptor's genetic disorder drug meets study goals
Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.
AP via Yahoo! News,
Mon Nov 23 08:05:21 PST 2009
• Found on Yahoo! News
Raptor's genetic disorder drug meets study goals
Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study. The company said the drug candidate DR C...
San Francisco Chronicle,
Mon Nov 23 08:40:36 PST 2009
• Found on Yahoo! News
Raptor Pharmaceutical announces Phase 2b results of DR Cysteamine trial
Raptor Pharmaceutical Corp., today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic ...
News-Medical-Net,
Mon Nov 23 04:25:22 PST 2009
• Found on Yahoo! News
Raptor's genetic disorder drug meets study goals
Raptor Pharmaceutical's genetic disorder drug meets midstage study goals
Newsday,
Mon Nov 23 08:37:29 PST 2009
• Found on Yahoo! News
Raptor's genetic disorder drug meets study goals
NOVATO, Calif.
Rocky Mount Telegram,
Mon Nov 23 08:22:36 PST 2009
• Found on Yahoo! News
Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Tre...
NOVATO, California, November 23 /PRNewswire/ -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP) today announced the presentation of clinical trial data on NGX426, the...
ITNews,
Mon Nov 23 03:44:49 PST 2009
• Found on Yahoo! News
Raptor's genetic disorder drug meets study goals
Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.
AP via Yahoo! Philippines News,
Mon Nov 23 08:05:00 PST 2009
• Found on Yahoo! News
Raptor's genetic disorder drug meets study goals
Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.
Seattle Times,
Mon Nov 23 08:21:55 PST 2009
• Found on Yahoo! News
Raptor's genetic disorder drug meets study goals
Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.
FOX 12 Idaho,
Mon Nov 23 08:29:35 PST 2009
• Found on Yahoo! News
Raptor's genetic disorder drug meets study goals
Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.
AP via Yahoo! Asia News,
Mon Nov 23 08:05:00 PST 2009
• Found on Yahoo! News
Raptor's genetic disorder drug meets study goals
Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.
AP via Yahoo! Singapore News,
Mon Nov 23 08:05:00 PST 2009
• Found on Yahoo! News
Raptor's genetic disorder drug meets study goals
Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.
WCAX-TV Vermont,
Mon Nov 23 08:16:25 PST 2009
• Found on Yahoo! News
Raptor's genetic disorder drug meets study goals
NOVATO, Calif.
The Daily Reflector,
Mon Nov 23 08:22:53 PST 2009
• Found on Yahoo! News
Raptor's genetic disorder drug meets study goals
Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.
KSWO Lawton-Wichita Falls,
Mon Nov 23 08:20:28 PST 2009
• Found on Yahoo! News
Raptor's genetic disorder drug meets study goals
Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.
AP via Yahoo! Finance,
Mon Nov 23 08:05:21 PST 2009
• Found on Yahoo! News
Raptor's genetic disorder drug meets study goals
Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.
Channel 8 San Diego,
Mon Nov 23 08:26:00 PST 2009
• Found on Yahoo! News